Tag Archives: medicines

NHS Costs and charging: Publicity, shame and complexity

Posted on July 3, 2015 by Julia Manning

Commenting on today’s press about Jeremy Hunt has created waves with his new plan to state the cost of medicines on the label and with his comment last night (July 2nd) on Question Time that he is not opposed to … Continue reading →

Posted in Finance | Tagged , , , , , , | Leave a comment

Bad for patients and bad for growth?

Posted on May 7, 2013 by Julia Manning

2020health today publish a review from a patient’s perspective of the Government’s plans to change the way medicines are priced. Featured in today’s FT (£) we point out that patients are usually blissfully unaware of pricing negotiations but the Government’s … Continue reading →

Posted in Innovation, Patients | Tagged , , , , , , , , , , | Leave a comment

Pfizer closure a blow to science and growth confidence

Posted on February 2, 2011 by Julia Manning

Whilst Pfizer are saying that their closure of their Kent-based research site is due to internal changes in priorities it highlights both fundamental changes in the approach to drug research and development (R&D) and the urgent need for the UK … Continue reading →

Posted in Drugs, Pharma | Tagged , , , , , | Leave a comment